As part of the celebrations around the upcoming 4 Nations Face-Off international tournament, the National Hockey League (NHL ...

Meet Minnesota Orchestra’s Susie Park. Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine manufacturing plant in northwest ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

While AstraZeneca confirmed no current jobs at the Speke site would be affected, the cancellation raises questions about Britain's investment climate. The Chancellor has recently attempted to shift ...

Confirming the reversal on Friday, a spokesperson for AstraZeneca said: "Following discussions with the current Government, we are no longer pursuing our planned investment in Speke. "Several factors ...

AstraZeneca has pulled out of plans to build a new £450m facility in Liverpool. AstraZeneca, which produced one of the Covid-19 jabs, has an existing site on Renaissance Way, Speke and during the ...

This is hardly the first time AstraZeneca has bristled at the U.K.’s business environment for the life sciences industry. Back in February 2023, AZ CEO Pascal Soriot attributed the company’s ...

LONDON, Jan 31 (Reuters) - AstraZeneca (AZN.L), opens new tab on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England ...

Fields is now on a drug approved by the Food and Drug Administration named Enhertu, developed and commercialized by biotech giants AstraZeneca and Daiichi Sankyo. Enhertu is not specifically ...

(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...

As­traZeneca says it plans to par­tic­i­pate in the next round of Medicare ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act. But this time around, the com­pa­ny says … ...

Credit: Roland Magnusson via Getty Images. AstraZeneca has received two separate recommendations from England’s National Institute for Health and Care Excellence (NICE) for the use of its lung cancer ...